QIAGEN N.V. Shareholders Approve Return Of Approximately $250 Million In Cash To Shareholders Via Synthetic Share Repurchase

Adjustment to capital structure through reduction in number of shares outstanding and direct capital repayment to shareholders expected to be completed in January 2017

Following the announcement of the synthetic share repurchase plan in August 2016, shareholders at an Extraordinary General Meeting of Shareholders (EGM) today approved all three proposals to amend the Company’s Articles of Association to allow for an adjustment in QIAGEN’s share capital in order to complete the related capital repayment. Similar approaches have previously been used by other large, multinational Dutch companies as an efficient way to provide returns to all shareholders, and to do so in a faster and more efficient way than through a traditional open-market share repurchase program.

The transactions are expected to be completed in early January 2017 following the expiration of a two-month creditor objection period, which is required by Dutch law and begins after filing of the EGM resolution with the Dutch Trade Register and publication in a Dutch daily newspaper.

Click here for full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={5889E407-DE47-4BF5-9B47-2DB06BAFBBAF}&lang=en

Contacts:

QIAGEN

Investor Relations
John Gilardi
ir@QIAGEN.com
+49-2103-29-11711

Public Relations
Dr. Thomas Theuringer
pr@QIAGEN.com
+49-2103-29-11826

SOURCE QIAGEN N.V.

MORE ON THIS TOPIC